Tashkent Pharmaceutical Institute - MBBS Fees, Admission & Eligibility 2026

Tashkent Pharmaceutical Institute holds a world ranking of #5313 and ranks #1 nationally in Uzbekistan. A top-20 national ranking in Uzbekistan indicates strong government funding, experienced faculty, and well-maintained infrastructure.

Tashkent Pharmaceutical Institute holds NMC approval, WHO listing — the recognitions that directly determine whether your degree is valid for medical practice. For Indian medical students, NMC recognition is non-negotiable — without it, a degree cannot be used for FMGE registration regardless of how highly ranked the university is in Uzbekistan.

Tashkent Pharmaceutical Institute's FMGE pass rate of 47.83% is a more direct measure of training quality than any global ranking. FMGE results reflect how well a university's curriculum and clinical training prepare students for the Indian licensing exam — something rankings based on research output or web visibility cannot capture.

Tashkent Pharmaceutical Institute, serving 7,800 students (100 MBBS seats per batch).

Founded in 1930, Tashkent Pharmaceutical Institute is a public institution with 96 years of operation in Uzbekistan. As a public university, it typically benefits from state funding, which supports infrastructure maintenance and faculty retention.

Tashkent Pharmaceutical Institute delivers its MBBS program in English. English-medium instruction in Uzbekistan eliminates the language barrier that affects clinical training and FMGE preparation at non-English universities.